baber/WOPTO huggingface dataset:
Patent JP-H0647324-B2 (JP)
IPC: B60C25/132
Filed: 1988-12-22
Abstract: PCT No. PCT/EP88/01193 Sec. 371 Date Sep. 14, 1989 Sec. 102(e) Date Sep. 14, 1989 PCT Filed Dec. 22, 1988 PCT Pub. No. WO89/06604 PCT Pub. Date Jul. 27, 1989.An apparatus for mounting a tire on a rim and removing it therefrom has a device for rotating the rim, which is embodied as a pneumatic motor having a rotor and a stator with radially arranged piston/cylinder units and cams disposed on a circle, a device for firmly holding the rim of self-centering arms that are pivotable via the pneumatic motor, a device for forcing the bead edges of the tire into the rim bed that comprises rollers acting simultaneously on both beads, and a device for pulling the bead edges from or onto the rim, with an element for bracing against the wheel flange. Via the hydraulic motor that drives the arms of the holding or chucking device, a rim is firmly held and once it is firmly clamped is rotated via the motor. The apparatus is operated completely pneumatically.
Patent JP-3110461-B2 (JP)
IPC: C07D411/04
Filed: 1994-06-07
Granted: 2000-11-20
Abstract: PCT No. PCT/CA94/00311 Sec. 371 Date Feb. 2, 1995 Sec. 102(e) Date Feb. 2, 1995 PCT Filed Jun. 7, 1994 PCT Pub. No. WO94/29301 PCT Pub. Date Dec. 22, 1994The present invention relates to a process for producing predominantly pure cis nucleoside analogues of formula (I), wherein X is S, or O; Y is S, CH2, O or CH(R); wherein R is azido or halogen; and R2 is a purine or pyrimidine base; via the coupling of a silylated purine or pyrimidine base in the presence of an appropriate Lewis acid with a bicyclic intermediate of formula (III) wherein Z is S or O; followed by conversion of the resulting intermediate of formula (II) to an alkyl ester and reduction to yield a compound of formula (I).    <IMAGE>  (I)   <IMAGE>  (II)   <IMAGE>  (III)
Patent JP-3041312-B2 (JP)
IPC: C12N1/20
Filed: 1991-12-26
Granted: 2000-05-15
Abstract: The invention relates to a method of bacteriological analysis for the selective detection of Salmonella and a medium for its implementation. The method is based on the specific capacity of Salmonella to ferment glucuronic acid or one of its salts, and not to produce  beta -galactosidase. The medium comprises a nutrient which is metabolized by the bacteria, a chromogenic or fluorigenic compound capable of being hydrolyzed by the enzyme  beta -galactosidase, glucuronic acid or one of its salts and a pH indicator.
Patent JP-3242653-B2 (JP)
IPC: C07D487/04
Filed: 1992-08-06
Granted: 2001-12-25
Abstract: A pyrroloazepine compound represented by general formula (I) or (II), a salt thereof, a process for the production thereof, and a remedy for the diseases of circulatory organs containing the same as the active ingredient. In general formula (I) or (II) Z1 represents H when there is a bond represented by the broken line, whereas when there is no such a bond, Z1 represents H and Z2 represents OH, or alternatively Z1 and Z2 are combined together to represent O or NOR1 (wherein R1 represents H, alkyl, aryl or aralkyl); R represents alkyl, cycloalkyl, cyclalkyl-alkyl, aryl or aralkyl; A represents alkylene, alkenylene or alkynylene; and Y represents optionally substituted heterocycle or ( alpha ) wherein R2 and R3 represent each H, alkyl, lower alkoxy, aryloxy-substituted alkyl, aryl or aralkyl. <CHEM>
Patent JP-2828340-B2 (JP)
IPC: C12N15/13
Filed: 1989-12-28
Granted: 1998-11-25
Abstract: Compsn. comprises a pure human-like immunoglobulin (Ig) which (a) reacts specifically with p55 Tac protein and/or (b) inhibits binding of human interleukin-2 (IL-2) to its receptor. Also new are (1) human-like Ig having 2 pairs of light/heavy chains and able to react specifically with an epitope of a human IL-2 receptor with affinity at least 10 power 8 per mole, the chains including complementarily determg. regions (CDR's) and human-like framework regions (FR's), the CDR's being from different Ig molecules than FR's; (2) humanised Ig (hIg) which can bind to IL-2 receptors and contain at least one CDR from anti-Tac antibody in a human-like FR contg. at least one amino acid from the anti-Tac antibody; (3) nucleic acid encoding for human-like FR and at least one murine CDR, and (4) cells transfected with nucleic acid.
Patent JP-2837957-B2 (JP)
IPC: C07D493/22
Filed: 1994-07-08
Granted: 1998-12-16
Abstract: PCT No. PCT/EP94/02297 Sec. 371 Date Dec. 22, 1995 Sec. 102(e) Date Dec. 22, 1995 PCT Filed Jul. 8, 1994 PCT Pub. No. WO95/03317 PCT Pub. Date Feb. 2, 1995This invention is directed to novel antiparasitic compounds of formula (I), wherein the broken line represents an optional bond, R1 and R4 being absent when this bond is present, R1, R3, R4 are independently H, OH, halo mercapto, oxo, oximino, or an organic radical, R2 and R7 are organic radicals, R6 is H or an organic radical and R12 is OH, halo, C1-C8 alkoxy, C1-C9 alkanoyloxy, or oximino optionally O-substituted by a C1-C8 alkyl, alkenyl, alkynyl, aryl, trialkylsilyl, aralkyl or C1-C9 alkanoyl group.
Patent JP-3844362-B2 (JP)
IPC: A61J17/00
Filed: 1997-06-20
Granted: 2006-11-08
Abstract: A pacifier of the dummy type comprises a bubble body (18) on which the child sucks, and a stop disc (16) against which the child's lips (22, 24) rest supportingly in the pacifier's position of use. The bubble body (18) and the stop disc (16) are interconnected through an intermediate transition and connecting portion (20) accommodating possible front teeth (26, 28)/gums. The bubble body (18) is given an asymmetrical shape in respect of its connection point on the transition and connecting portion (20), comprising at least one elongate leg (18a) sloping downwardly in its longitudinal direction towards the free end thereof, forming an impact and support face for the adjacent portion of the tongue (34). The stop disc (16) comprises an upper and a lower portion (16a, 16b) somewhat displaced from each other in the longitudinal axial direction of the pacifier, forming suitable stop and support faces for the child's lips (22, 24).
Patent JP-H07103484-B2 (JP)
IPC: D01C1/04
Filed: 1986-10-17
Abstract: The process for biochemical retting of phloem-fiber plants such as hemp, flax, ramie, jute, kenaf, etc. permits separation of the fibers of the bundle for subsequent utilization in the textile or paratextile industry.  The process comprises treating the fibrous plants with at least one SPS-ase enzyme and preferably a mixture of enzymes comprising  beta -glucanase, pectinase and SPS-ase.
Patent JP-3252912-B2 (JP)
IPC: B02C18/02
Filed: 1994-08-18
Granted: 2002-02-04
Abstract: PCT No. PCT/EP94/02741 Sec. 371 Date Mar. 25, 1996 Sec. 102(e) Date Mar. 25, 1996 PCT Filed Aug. 18, 1994 PCT Pub. No. WO95/05898 PCT Pub. Date Mar. 2, 1995A material comminution device has a housing. Cutters extend within the housing and move toward each other in a scissor-like manner. The cutters extend parallel to each other along a bottom portion and diverge along a top portion, and consist of comb-like rows of spaced blades that mesh with each other. The blades carry out at the same time a shearing movement and a swivelling movement around an axis by means of a crank mechanism.
Patent JP-2824538-B2 (JP)
IPC: C07B61/00
Filed: 1990-05-08
Granted: 1998-11-11
Abstract: The method uses a starting material which is a liquid mixture consisting of a formaldehyde proportion comprised between 48 and 55 % by weight, a methanol proportion comprised between 20 and 30 % by weight and a water proportion comprised betweeen 32 and 15 % by weight; the liquid mixture is obtained from a tapping which is effected from a plant for the continuous preparation of urea-formaldehyde resins and glues, immediately after having subjected the methanol to catalytic oxidation via air, condensation of the gases evolving from said catalytic oxidation and separation between condensed products and uncondensed gases. These solutions may be applied to formaldehyde reactions wherein it is of interest to reduce the amount of water present in conventional solutions and also to use the methanol for example as solvent for the final product obtained.
Patent JP-3037434-B2 (JP)
IPC: B41M5/50
Filed: 1995-08-17
Granted: 2000-04-24
Abstract: A print-through form comprises a top and a base layer with the top layer having a pattern of openings in at least one region, the pattern of openings having center-to-center distances substantially less than the size of characters or other elements to be printed. Ink applied to the region or regions with openings forms characters on the top layer by marking the area between the openings, and on the base layer in the same operation through the openings, marking the area on the base layer exposed by the openings through the first layer. More than two copies in a single printing pass may be accomplished with forms of more than two layers, wherein the patterns of openings expose area on all the intermediate layers and the base layer. In various embodiments forms may comprise sheets affixed by peelable adhesive, by folding larger sheets, and by edge gluing with removable strips made by perforation lines. Some forms are made to be fed through traction feeders from continuous webs.
Patent JP-3547453-B2 (JP)
IPC: A61P23/00
Filed: 1996-07-26
Granted: 2004-07-28
Abstract: An apparatus, product formulation, and method for improved dermal permeation of pharmaceuticals wherein the apparatus includes a thin drug formulation reservoir and a heat-generating chamber separated by a first non-permeable wall, wherein the reservoir and chamber are formed in or supported by a housing. The drug formulation reservoir houses or is capable of housing a predetermined amount of a formulation containing pharmaceutically-active agent(s). The heat-generating/temperature-regulating chamber includes a medium for generating controlled heat, preferably a chemical composition made of carbon, iron, water and/or salt which is activated upon contact with air (oxygen). The function of the heat-gencrating,/tcmpcrature-rcgulating clement is to heat the user's skin, rapidly bring the skin temperature to a desired and elevated narrow range and keep it in this range for sufficient time to obtain more rapid, enhanced and less variable dermal absorption of selected pharmaceutically-active agents and to obtain improved clinical effects. Structure for controlling the generation of heat is also disclosed. The apparatus may optionally include a spacing or standoff structure which spans the drug formulation reservoir between the non-permeable wall and the user's skin surface for maintaining a predetermined thickness of the drug formulation on the user's skin surface. Also, a novel product formulation which can be used with the apparatus which uses high percentage of eutectic mixture of local anesthetics to reduce the overall degradation rate of the local anesthetic compound(s) in formulations which are subject to hydrolysis.
Patent JP-4191796-B2 (JP)
IPC: C12N15/12
Filed: 1996-08-14
Granted: 2008-12-03
Abstract: The present invention is related to nucleic acid molecules, the peptides encoded by said nucleic acid molecules and the inhibitors directed against said nucleic acid molecules or said peptides. The present invention concerns also the pharmaceutical composition, the diagnostic and/or dosage device comprising said products and methods for identifying the inhibitors according to the invention. <IMAGE>
Patent JP-H0676383-B2 (JP)
IPC: C07D401/10
Filed: 1992-04-10
Abstract: The present invention provides new antiviral compounds, i.e., michellamines and derivatives and pharmacologically acceptable salts thereof, methods for isolating such antiviral compounds from a plant species of the genus Ancistrocladus, antiviral compositions containing such antiviral compounds, and methods of using such antiviral compounds for treating patients with viral infections. The antiviral compounds of the present invention inhibit the reproduction and cytopathicity of human acquired immunodeficiency viruses.
Patent JP-H0819441-B2 (JP)
IPC: B22F1/10
Filed: 1990-05-25
Abstract: Shaped parts are formed from a powder having the desired chemistry of the finished part by mixing the powder with a thermosetting condensation resin that acts as a binder. The resin may be partially catalyzed, or additives or surfactants added to improve rheology, mixing properties, or processing time. Upon heating, the inherently low viscosity mixture will solidify without pressure being applied to it. A rigid form is produced which is capable of being ejected from a mold. Pre-sintered shapes or parts are made by injection molding, by using semi-permanent tooling, or by prototyping. Binder removal is accomplished by thermal means and without a separate debinding step, despite the known heat resistance of thermosetting resins. Removal is due to the film forming characteristic of the binder leaving open the part's pores, by providing oxidizing conditions within the part's pores as the part is heated, and by insuring that the evolving resin vapor diffuses through the pores by heating the part in a vacuum.
Patent JP-3964457-B2 (JP)
IPC: A61B5/15
Filed: 1995-11-27
Granted: 2007-08-22
Abstract: A blade type lancet assembly which can be easily maintained in a germfree state. The lancet assembly (10) comprises a lancet structure and a holder (16) combined with the lancet structure. The lancet structure includes a lancet member (40) having a piercing element and an ejector (42) for ejecting the element, and the exposed portion of the piercing element is covered with a resin. <IMAGE>
Patent JP-3961569-B2 (JP)
IPC: H01M50/426
Filed: 1996-11-15
Granted: 2007-08-22
Abstract: Disclosed is a novel hybrid polymeric electrolyte formed of a closed-cell cellular polymer foam impregnated with a non-aqueous electrolytic liquid, which comprises a plurality of closed cells defined by cell walls constituting a continuous solid-phase matrix which is impregnated with the non-aqueous electrolytic liquid to form a continuous solid-phase domain, in which the plurality of closed cells are substantially filled with a non-aqueous electrolytic liquid to form a plurality of liquid phase domains which are dispersed in the above-mentioned continuous solid-phase domain. The hybrid polymeric electrolyte of the present invention has not only high ionic conductivity and high mechanical strength, but also has the ability to prevent the non-aqueous electrolytic liquid from leakage, so that the electrolyte of the present invention can be advantageously used in various non-aqueous electrochemical devices. That is, the non-aqueous electrochemical device comprising the hybrid polymeric electrolyte of the present invention exhibits not only excellent electrochemical performance, but also has high ability to retain an electrolytic liquid therein, so that the electrochemical device has excellent safety and is highly reliable in practical use thereof.
Patent JP-3786421-B2 (JP)
IPC: F15C4/00
Filed: 1995-02-17
Granted: 2006-06-14
Abstract: The micro flow line is taken through a channel (7) etched into a substrate (1) and past an array of micro capillaries where the fluid forms a pattern of micro meniscuses (6), with the fluid contained in the duct via the surface tension in the capillaries. Small amounts of the fluid (5) to be injected into the main flow are dosed into the capillaries from where they spread into the flow. The diode is assembled from a sandwich of etched substrates including silicon, glass, ceramic, metal, etc. and bonded together using conventional thin/thick film techniques. For silicon an orientation of <100> or <110> is used.
Patent JP-4505565-B2 (JP)
IPC: G10L19/02
Filed: 1997-04-30
Granted: 2010-07-21
Abstract: The transmitter receives the digital information signal with the specific first sampling frequency, and lowpass filters and downpasses the signal to obtain a lowpass filtered version of the signal with a specific second sampling frequency, smaller than the first. A second filter provides digital processomg to the signal, then upsamples (22) the lowpass filtered version to obtain a upsampled version with a third sampling frequency, equal to the first. A third filter (28) filters the upsampled signal to obtain a second filtered version. A signal combiner (20) combines the digital information signal and the second filtered version, to obtain (34) a difference signal. A second combiner combines the lowpass filtered version and the difference signal to obtain a transmission signal, for transmission via the transmission medium.
Patent JP-4140739-B2 (JP)
IPC: G02B6/42
Filed: 1998-01-15
Granted: 2008-08-27
Abstract: The power handling capability of polymer fibers is increased by broadening an input intensity profile, which is typically Gaussian, without significantly decreasing the efficiency of coupling light into a polymer fiber. The method for increasing the power handling capability of polymer fibers includes the steps of: a) emitting light having a Gaussian intensity profile from a fiber light source; b) broadening the Gaussian intensity profile so that energy at the center of the Gaussian intensity profile is distributed to the perimeter to reduce the peak power intensity of the emitted light before it is launched into the polymer fiber; c) transmitting the emitted light into at least one polymer fiber. Preferably, a fused bundle is used to broaden the intensity profile and preferably the fused bundle has an angled input end face. As a result, more total power can be coupled into the polymer fiber while keeping below the melting threshold caused by the light absorption-enabling, for example, power in excess of 1 Watt to be transmitted through a 1-mm diameter PMMA fiber.
Patent PL-149422-B2 (PL)
Title: Self-curing forming mass or a core mass
IPC: B22C1/20
Filed: 1987-03-11
Abstract: The sand composition of the invention consists of 100 parts by weight of silica sand, 0.4 - 1.2 parts by weight of acid type hardener and 1.2-2.0 parts by weight of urea-formaldehyde, urea-furfuryl-formaldehyde, phenol-formaldehyde or phenol-furturyl-formaldehyde resin binder, comprising 0.2 - 3 percent by weight of an  alpha -functional silane. Silanes specified include alpha -ethylenediamine-methyl-triethexysilane or  alpha -propylenediamine-methyl-triethexysilane, and the hardener specified in para-toluene-sulphonic acid.
Patent ES-2645028-B2 (ES)
Title: Preparación farmacéutica única y estable que contiene berberina, en formulación de liberación lenta, una estatina y ubiquinol para el tratamiento de la enfermedad cardiovascular y los factores de riesgo asociados
Inventor: GOMEZ GARRE MARIA D
IPC: A61K31/05
Filed: 2017-10-13
Granted: 2018-06-04
Abstract: Preparación farmacéutica única y estable que contiene berberina, en formulación lenta, con una estatina y ubiquinol para el tratamiento de la enfermedad cardiovascular y de sus factores de riesgo asociados. La combinación de berberina, en una formulación de liberación lenta para asegurar su bioasimilación, recubierta de una matriz de estatina y ubiquinol en una presentación única con calidad medicamento constituirá un tratamiento de alta eficacia y más barato que los actuales. La combinación de distintos mecanismos de acción complementarios, permitirá disminuir la dosis de estatina, lo cual se traducirá en menos efectos secundarios, también reducidos por el suplemento en ubiquinol (coenzima Q10), por lo que sería una formulación más saludable. La administración será oral, por lo que se evitarán los pinchazos que siempre son muy impopulares entre los pacientes. Finalmente, la presencia de todos los componentes en un único medicamento favorecerá aún más la adhesión al tratamiento.
Patent AU-2001236788-B2 (AU)
Title: Flexible reflective insulating structures
Inventor: HEIFETZ RAPHAEL
IPC: E04B1/78
Filed: 2001-02-09
Granted: 2005-09-15
Abstract: A flexible reflective insulating structure includes a layer of flexible fiber-based material, and a flexible metallic layer having a first surface of emissivity less than 0.1. The metallic layer is attached to the layer of fiber-based material with its first surface facing towards the layer of fiber-based material. The fiber-based material is preferably attached to the metallic layer in a manner such that the emissivity of at least about 85% of the first surface, and preferably at least about 95% and most preferably at least about 97% is substantially unaffected.
Patent AU-2002236669-B2 (AU)
Title: Dredge cutterhead
Inventor: OLLINGER CHARLES G
IPC: E02F3/92
Filed: 2001-12-31
Granted: 2007-06-07
Abstract: A dredge cutterhead has a plurality of helical arms inter-connecting a hub and a ring. Each of the arms has a front leading edge for attachment of cutting teeth. In one aspect, each of the arms has a trough portion, and the arm is shaped such that dredged material is directed toward the ring along the center of the trough portion. In another aspect, the ring of the cutterhead defines an annular channel for receiving loosened material.
Patent AU-2002257794-B2 (AU)
Title: Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension
Inventor: CARMELIET PETER
IPC: G01N33/74
Filed: 2002-04-24
Granted: 2007-01-25
Abstract: The current invention relates to the field of hypoxia-induced disorders and more specifically to the use of hypoxia inducible factor 2alpha as a target in a method for the screening for molecules that can be used for the treatment of pulmonary hypertension. The invention further relates to the use of HIF-2alpha and/or of the HIF-2alpha inducible protein VEGF for the treatment of neonatal respiratory distress syndrome.
Patent AU-2002301015-B2 (AU)
Title: Apparatus for keeping hot and for transporting dishes using a motor vehicle
Inventor: DELZANNO ROBERTO
IPC: A47J39/02
Filed: 2002-09-13
Granted: 2008-07-24
Abstract: A pizza delivery van has a motor with an exhaust system with a by-pass pipe to a heat exchanger (3) within a thermally insulated food storage compartment (2). The compartment is essentially rectangular and has an access door. The compartment has an air inlet and an air outlet and a circulating flow of warm air is maintained in the compartment by a fan.
Patent AU-2002311598-B2 (AU)
Title: Milling cutter and cutting insert therefor
Inventor: ULIANITSKY DANIEL
IPC: B23C5/20
Filed: 2002-06-16
Granted: 2007-06-21
Abstract: An indexable cutting insert for use in a milling cutter. The cutting insert having four identical side surfaces extending between generally square shaped top and bottom surfaces with two diametrically opposite protuberances extending away from each other in a top or bottom view of the cutting insert. The cutting insert has eight identical major and minor cutting edges. The milling cutter having the general form of a circular disk with a plurality of the cutting inserts releasably mounted in insert pockets angularly around the periphery of the cutter. The cutting inserts are arranged to produce a profile on a workpiece having a central straight section and two beveled sections on either side of the central straight section.
Patent AU-2002347731-B2 (AU)
Title: Method of rock drilling
Inventor: OLSSON MAGNUS
IPC: E21B1/00
Filed: 2002-11-07
Granted: 2006-11-02
Abstract: Method of rock drilling comprising forward feeding of a rock drilling machine (3) toward a rock (33), drilling a short distance in the rock with reduced values on impact pressure (38) and feed pressure (36) and after that transition to full impact pressure and feed pressure with which a bore hole is finished, whereby the pressure in a recoil damper (21) at the rock drilling machine (3) is read and stored in a memory (44), that the rock drilling machine (3) is fed toward the rock (33) with rotation and impact device inactive until a rock drilling tool (2) connected to the rock drilling machine reaches the rock, that the feeding toward the rock is interrupted when the pressure (35) in the recoil damper (21) exceeds the value stored in the memory (44) with a predetermined amount and that the bore hole after that is drilled.